Literature DB >> 31368453

Glucagonoma syndrome with atypical necrolytic migratory erythema.

Shujuan He1, Weihui Zeng1, Songmei Geng1, Jinjing Jia2.   

Abstract

Necrolytic migratory erythema is most commonly associated with glucagonoma syndrome. We report a rare case of glucagonoma syndrome with necrolytic migratory erythema presenting as pruritic papules and follicular pustules in a 57-year-old woman; showing eosinophilic infiltration on histology. However, the final diagnosis was confirmed by demonstrating neuroendocrine tumour on histopathological examination of the liver metastases. Nutrition therapy was administered as a palliative treatment. This case also highlights the atypical clinical features and nonspecific histology of necrolytic migratory erythema which makes the diagnosis difficult.

Entities:  

Keywords:  Glucagonoma syndrome; necrolytic migratory erythema; nutrition therapy

Year:  2021        PMID: 31368453     DOI: 10.4103/ijdvl.IJDVL_588_18

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  8 in total

1.  Peripheral amino acid and fatty acid infusion for the treatment of necrolytic migratory erythema in the glucagonoma syndrome.

Authors:  Erik K Alexander; Malcolm Robinson; Maryjane Staniec; Robert G Dluhy
Journal:  Clin Endocrinol (Oxf)       Date:  2002-12       Impact factor: 3.478

2.  Delayed diagnosis of glucagonoma syndrome: a case report.

Authors:  Jia Huo; Ping Liu; Xing Chen; Jiawen Wu; Jingang An; Jianwen Ren
Journal:  Int J Dermatol       Date:  2016-11       Impact factor: 2.736

3.  Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.

Authors:  Catherine Tremblay; Isabelle Marcil
Journal:  J Cutan Med Surg       Date:  2017-06-29       Impact factor: 2.092

4.  Normoglycemic glucagonoma syndrome associated with necrolytic migratory erythema.

Authors:  R Feldmann; S Wahl; A Steiner
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-03-05       Impact factor: 6.166

5.  Glucagonoma-Associated Necrolytic Migratory Erythema: The Broad Spectrum of the Clinical and Histopathological Findings and Clues to the Diagnosis.

Authors:  Ferdinand Toberer; Wolfgang Hartschuh; Katharina Wiedemeyer
Journal:  Am J Dermatopathol       Date:  2019-03       Impact factor: 1.533

Review 6.  The glucagonoma syndrome and necrolytic migratory erythema: a clinical review.

Authors:  Andre P van Beek; Ellen R M de Haas; Willem A van Vloten; Cees J M Lips; Janine F M Roijers; Marijke R Canninga-van Dijk
Journal:  Eur J Endocrinol       Date:  2004-11       Impact factor: 6.664

Review 7.  A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema.

Authors:  Starling Tolliver; Jaqueline Graham; Benjamin H Kaffenberger
Journal:  Int J Dermatol       Date:  2018-02-16       Impact factor: 2.736

Review 8.  Glucagonoma syndrome: a review and update on treatment.

Authors:  A M John; R A Schwartz
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-07-16       Impact factor: 6.166

  8 in total
  2 in total

1.  Necrolytic migratory erythema is an important visual cutaneous clue of glucagonoma.

Authors:  Wei Li; Xue Yang; Yuan Deng; Yina Jiang; Guiping Xu; Enxiao Li; Yinying Wu; Juan Ren; Zhenhua Ma; Shunbin Dong; Liang Han; Qingyong Ma; Zheng Wu; Zheng Wang
Journal:  Sci Rep       Date:  2022-05-31       Impact factor: 4.996

2.  Application of Somatostatin, Chemotherapy Combined with TAE in Heterogeneous Glucagonoma Presented with Necrolytic Migratory Erythema.

Authors:  Chaoyong Shen; Jiaoxue He; Xiaoyan Le; Linmao Zheng; Dan Cao
Journal:  Onco Targets Ther       Date:  2019-12-20       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.